CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a...
Phase 1, Phase 2
Boston, Massachusetts, United States
This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer.The drug involved ...
Phase 2
Boston, Massachusetts, United States and 4 other locations
with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate cancer and whether the combination is effective in shr ...
Phase 1
Boston, Massachusetts, United States and 2 other locations
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Boston, Massachusetts, United States and 92 other locations
pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...
Phase 1
Providence, Rhode Island, United States and 15 other locations
improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (A...
Boston, Massachusetts, United States
purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...
Phase 1
Boston, Massachusetts, United States and 7 other locations
Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...
Phase 1
Boston, Massachusetts, United States and 17 other locations
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
Boston, Massachusetts, United States and 9 other locations
The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...
Phase 1
Boston, Massachusetts, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal